Substituted fused [1,2]imidazo[4,5-C] ring compounds and methods
    6.
    发明授权
    Substituted fused [1,2]imidazo[4,5-C] ring compounds and methods 失效
    取代的稠合[1,2]咪唑并[4,5-C]环化合物和方法

    公开(公告)号:US08093390B2

    公开(公告)日:2012-01-10

    申请号:US11884186

    申请日:2006-02-10

    IPC分类号: C07D513/00 A61K31/44

    CPC分类号: C07D498/14 C07D519/00

    摘要: Fused [1,2]imidazo[4,5-c] ring compounds, e.g., fused [1,2]imidazo[4,5-c]quinolines and [1,2]imidazo[4,5-c]naphthyridines, with a substituent, e.g., a substituted alkoxy substituent, at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.

    摘要翻译: 熔融[1,2]咪唑并[4,5-c]环化合物,例如稠合[1,2]咪唑并[4,5-c]喹啉和[1,2]咪唑并[4,5-c]萘啶, 在6,7,8或9位具有取代基的取代烷氧基取代基,含有化合物,中间体,制备方法和这些化合物作为免疫调节剂的用途的药物组合物,用于诱导细胞因子生物合成 公开了动物和治疗包括病毒和肿瘤疾病在内的疾病。